VC-backed Aeglea BioTherapeutics promotes York to CFO
Aeglea BioTherapeutics Inc, a biopharmaceutical company focused on treating tumor metabolism, has promoted Charles N. York to chief financial officer. Previously, York was the company's vice president of finance and accounting. He first joined Aeglea in 2013, acting intially as a consultant before becoming a full-time employee during the summer of 2014. Aeglea's backers include Lilly Ventures, Novartis Venture Fund, UT Horizon Fund, OrbiMed, Jennison Associates (on behalf of clients), Venrock, RA Capital Management, Rock Springs Capital, Ally Bridge Group and Cowen Investments.
28 September 2015•3 mins read
